Iambic Therapeutics, Inc.: director Shalini Sharp received 20,300 shares

What happened The Form 4 reports that Shalini Sharp, a director of Iambic Therapeutics, Inc., received a grant of 20,300 shares as a derivative award at a price of $0.00 on Oct 14, 2026 (total value $0.00).

Key details

• Transaction date and price: Oct 14, 2026; $0.00 per share.
• Filing date: Oct 16, 2026.
• Shares owned after the transaction: not reported in the Form 4.
• Transaction type: award/grant (derivative).
• Footnote F1: all of the shares subject to the option vest on Oct 14, 2027.
• No late-filing flag noted in the provided data.

Why it may matter

• This was an award/grant of derivative securities, not a market purchase or sale.
• The award is subject to vesting on Oct 14, 2027, per the footnote.
• This filing does not show why the insider traded or why the company acted.